Indication
Renal osteodystrophy
Renal osteodystrophy is a skeletal complication of chronic kidney disease characterized by alterations in bone morphology and histology. Read more about Renal osteodystrophy
29 drugs 24 manufacturers
Drugs that treat it
Common Renal osteodystrophy therapies.
ROCALTROL (calcitriol)
ROCALTROL (calcitriol)
CALCITRIOL
CALCITRIOL
CALCITRIOL
CALCITRIOL
CALCITRIOL
CALCITRIOL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonRenal osteodystrophy is a skeletal complication of chronic kidney disease characterized by alterations in bone morphology and histology.
It represents the bone-specific component of the broader chronic kidney disease–mineral and bone disorder (CKD-MBD) syndrome.
Pathophysiologically driven by impaired renal phosphate excretion, reduced calcitriol synthesis, secondary hyperparathyroidism, and abnormal calcium homeostasis, the condition disrupts normal bone turnover, mineralization, and volume.
Definitive histologic classification via bone biopsy reveals a spectrum of lesions, including high-turnover osteitis fibrosa cystica, low-turnover adynamic bone disease or osteomalacia, and mixed forms, clinically manifesting as bone pain, skeletal deformities, and heightened fracture risk.
- nih.gov
Renal osteodystrophy is a skeletal complication of chronic kidney disease characterized by alterations in bone morphology and histology It represents the bone-specific component of the broader chronic kidney disease–mineral and bone disorder (CKD-MBD) syndrome
- kdigo.org
Renal osteodystrophy is a skeletal complication of chronic kidney disease characterized by alterations in bone morphology and histology Pathophysiologically driven by impaired renal phosphate excretion, reduced calcitriol synthesis, secondary hyperparathyroidism, and abnormal calcium homeostasis, the condition disrupts normal bone turnover, mineralization, and volume Definitive histologic classification via bone biopsy reveals a spectrum of lesions, including high-turnover osteitis fibrosa cysti...
- nih.gov
It represents the bone-specific component of the broader chronic kidney disease–mineral and bone disorder (CKD-MBD) syndrome
- nih.gov
Pathophysiologically driven by impaired renal phosphate excretion, reduced calcitriol synthesis, secondary hyperparathyroidism, and abnormal calcium homeostasis, the condition disrupts normal bone turnover, mineralization, and volume
- nih.gov
Pathophysiologically driven by impaired renal phosphate excretion, reduced calcitriol synthesis, secondary hyperparathyroidism, and abnormal calcium homeostasis, the condition disrupts normal bone turnover, mineralization, and volume Definitive histologic classification via bone biopsy reveals a spectrum of lesions, including high-turnover osteitis fibrosa cystica, low-turnover adynamic bone disease or osteomalacia, and mixed forms, clinically manifesting as bone pain, skeletal deformities, and ...
- nih.gov
Definitive histologic classification via bone biopsy reveals a spectrum of lesions, including high-turnover osteitis fibrosa cystica, low-turnover adynamic bone disease or osteomalacia, and mixed forms, clinically manifesting as bone pain, skeletal deformities, and heightened fracture risk
Personalize your experience
Follow Renal osteodystrophy and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.